Deutsche Zeitschrift für Onkologie 2008; 40(1): 20-22
DOI: 10.1055/s-2008-1044038
Forschung

© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Krebs und Telomere

Oliver Zschenker, John P. Murnane
Further Information

Publication History

Publication Date:
02 April 2008 (online)

Zusammenfassung

Krebszellen haben im Allgemeinen kürzere Telomere als normale Zellen. Im Gegensatz zu normalen Zellen haben sie jedoch durch Aktivierung der Telomerase oder anderer Mechanismen einen Weg gefunden, die Telomerlänge aufrechtzuerhalten und so den Zelltod zu umgehen. Neue Forschungsergebnisse zeigen, dass die Telomerbiologie diese Mechanismen stören oder beeinflussen kann und somit möglicherweise in Zukunft ein weiteres Mittel im Kampf gegen den Krebs darstellen wird.

Summary

In general, cancer cells have shorter telomeres than normal somatic cells. However, compared to normal cells, they use reactivation of telomerase or other mechanisms to maintain telomere length and in consequence to bypass cell death. New results indicate that telomere biology might be a good tool for the fight against cancer in the future by disturbing or influencing these mechanisms.

Literatur

  • 01 Artandi S E, Attardi L D. Pathways connecting telomeres and p 53 in senescence, apoptosis, and cancer.  Biochemical and Biophysical Research Communications. 2005;  331 (3) 881-890
  • 02 Azzalin C M, Reichenbach P, Khoriauli L, Giulotto E, ingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends.  Science. 2007;  318 (5851) 798-801
  • 03 Bailey S M, Murnane J P. Telomeres, chromosome instability and cancer.  Nucleic Acids Research. 2006;  34 (8) 2408-2417
  • 04 Calcagnile O, Gisselsson D. Telomere dysfunction and telomerase activation in cancer-a pathological paradox?.  Cytogenetic and Genome Research. 2007;  118 (2-4) 270-276
  • 05 Lange T de. Telomere dynamics and genome instability in human cancer. In: Blackburn EH, Greider CW (Eds.): Telomeres. Plainview, NY, USA; Cold Spring Harbor Press 1995: 265-293
  • 06 Lange T de. Shelterin: the protein complex that shapes and safeguards human telomeres.  Genes & Development. 2005;  19 (18) 2100-2110
  • 07 Feldser D M, Greider C W. Short telomeres limit tumor progression in vivo by inducing senescence.  Cancer Cell. 2007;  11 (5) 461-469
  • 08 Jeggo P A, Taccioli G E, Jackson S P. Menage a trois: double strand break repair, V(D)J recombination and DNA-PK.  Bioessays. 1995;  17 (11) 949-957
  • 09 Karlseder J, Hoke K, Mirzoeva O K, Bakkenist C, Kastan M B, Petrini J H, Lange T de. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response.  PLoS Biology. 2004;  2 (8) E240
  • 10 Kusumoto R, Muftuoglu M, Bohr V A. The role of WRN in DNA repair is affected by post-translational modifications.  Mechanisms of Ageing and Development. 2007;  128 (1) 50-57
  • 11 Moyzis R K, Buckingham J M, Cram L S, Dani M, Deaven L L, Jones M D, Meyne J, Ratliff R L, Wu J R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.  Proceedings of the National Academy of Sciences of the United States of America. 1988;  85 (18) 6622-6626
  • 12 Murnane J P. Telomeres and chromosome instability.  DNA Repair. 2006;  5 (9-10) 1082-1092
  • 13 Ricchetti M, Dujon B, Fairhead C. Distance from the chromosome end determines the efficiency of double strand break repair in subtelomeres of haploid yeast.  Journal of Molecular Biology. 2003;  328 (4) 847-862
  • 14 Saintigny Y, Makienko K, Swanson C, Emond M J, Monnat Jr R J. Homologous recombination resolution defect in werner syndrome.  Molecular and Cellular Biology. 2002;  22 (20) 6971-6978
  • 15 Salk D. Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations.  Human Genetics. 1982;  62 (1) 1-5
  • 16 Shin J S, Hong A, Solomon M J, Lee C S. The role of telomeres and telomerase in the pathology of human cancer and aging.  Pathology. 2006;  38 (2) 103-113
  • 17 Slijepcevic P, Al-Wahiby S. Telomere biology: integrating chromosomal end protection with DNA damage response.  Chromosoma. 2005;  114 (4) 275-85
  • 18 Wellinger R J, Sen D. The DNA structures at the ends of eukaryotic chromosomes.  European Journal of Cancer. 1997;  33 (5) 735-749
  • 19 Yaar M, Eller M S, IPanova I, Kubera J, Wee L H, Cowan K H, Gilchrest B A. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells.  Breast Cancer Research. 2007;  9 (1) R13

Korrespondenzadresse

Dr. Oliver Zschenker

University of California San Francisco
(UCSF)
Department of Radiation Oncology

1855 Folsom Street, MCB 200

San Francisco, CA 94103

USA

Email: ozschenker@radonc.ucsf.edu